The Cigna Group (NYSE:CI) Shares Purchased by Claro Advisors LLC

Claro Advisors LLC grew its stake in shares of The Cigna Group (NYSE:CIFree Report) by 40.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,480 shares of the health services provider’s stock after purchasing an additional 710 shares during the quarter. Claro Advisors LLC’s holdings in The Cigna Group were worth $859,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of CI. Concord Asset Management LLC VA grew its stake in The Cigna Group by 11.4% during the 3rd quarter. Concord Asset Management LLC VA now owns 1,075 shares of the health services provider’s stock worth $372,000 after buying an additional 110 shares during the last quarter. Adero Partners LLC grew its position in shares of The Cigna Group by 4.5% during the third quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock worth $273,000 after acquiring an additional 34 shares during the last quarter. Seizert Capital Partners LLC grew its position in shares of The Cigna Group by 203.0% during the third quarter. Seizert Capital Partners LLC now owns 125,529 shares of the health services provider’s stock worth $43,488,000 after acquiring an additional 84,096 shares during the last quarter. Turtle Creek Wealth Advisors LLC increased its holdings in shares of The Cigna Group by 3.5% in the 3rd quarter. Turtle Creek Wealth Advisors LLC now owns 15,261 shares of the health services provider’s stock valued at $5,287,000 after acquiring an additional 510 shares during the period. Finally, KPP Advisory Services LLC raised its position in The Cigna Group by 8.6% in the 3rd quarter. KPP Advisory Services LLC now owns 1,277 shares of the health services provider’s stock valued at $442,000 after purchasing an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on CI. JPMorgan Chase & Co. lifted their price objective on shares of The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. Jefferies Financial Group boosted their price target on The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th. StockNews.com cut The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $394.00 price target (up from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $394.64.

Check Out Our Latest Analysis on CI

The Cigna Group Stock Performance

Shares of CI opened at $321.52 on Monday. The company has a market capitalization of $89.43 billion, a PE ratio of 30.33, a P/E/G ratio of 0.97 and a beta of 0.51. The Cigna Group has a 52-week low of $253.95 and a 52-week high of $370.83. The company has a 50-day simple moving average of $338.88 and a 200-day simple moving average of $339.42. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71.

The Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The company had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company’s revenue for the quarter was up 29.8% on a year-over-year basis. During the same period last year, the firm earned $6.77 EPS. Equities research analysts predict that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be given a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.74%. The Cigna Group’s payout ratio is 52.83%.

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.